UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
March 27, 2001
- ------------------
(Date of earliest event reported)


LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission          (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                   Number)


358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)

336-229-1127
- ------------
(Registrant's telephone number, including area code)




ITEM 9. Regulation FD Disclosure.

   Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced
that Thomas P. Mac Mahon, chairman and chief executive officer,
is scheduled to speak at the Banc of America Securities Health
Care Conference in Las Vegas on March 27.  The presentation will
be webcast live at 1:30 p.m. Pacific Standard Time/4:30 p.m.
Eastern Standard Time, with a rebroadcast through April 11,
2001, and may be heard online at www.labcorp.com.  To comply
with the Securities and Exchange Commission's Regulation FD, the
Company is filing this report to update all investors on its
outlook.

   At the conference, Mr. Mac Mahon will reiterate Company
guidance for 2001, as filed in an 8K on February 14, 2001.  Mr.
Mac Mahon will state, "We expect revenue growth of 10 percent to
11 percent, with a bad debt rate of 9.7 percent of sales, EBITDA
margins of approximately 20.5 percent to 21 percent of sales,
and EPS growth of approximately 45 percent to 50 percent.

   The statements in this report which are not historical facts
or information may be forward-looking statements.  These
forward-looking statements involve risks and uncertainties that
could cause the outcome to be materially different.  Certain of
these risks and uncertainties are listed in the Laboratory
Corporation of America-registered trademark-Holdings 2000 Form
10-K and subsequent filings.



SIGNATURES

Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                        (Registrant)

               By:/s/ BRADFORD T. SMITH
                  ----------------------------------
                      Bradford T. Smith
                      Executive Vice President,
                      General Counsel, Secretary
                      and Compliance Officer



Date: March 27, 2001